EXANTEMA GENERALIZADO Y TROMBOEMBOLISMO PULMONAR TRAS LA ADMINISTRACIÓN DE LA VACUNA Ad26.COV2-S EN PACIENTE CON ANTECEDENTE RECIENTE DE INFECCIÓN POR SARS-COV2 (COVID-19): REPORTE DE UN CASO

Abstract

Several vaccines have appeared in recent times given the need for vaccinations against SARS-Cov2 (COVID-19) infection. General concern about their safety and possible adverse events has also emerged. We present the case of a patient with recent history of COVID-19 pneumonia who presented generalized exanthema and pulmonary embolism after being immunized withCOVID-19 Vaccine Janssen (Ad26.COV2-S).